We illustrated this shift in TGF-β signaling by using the human MCF10A breast cancer progression model that consists of indolent (T1K), malignant nonmetastatic (Ca1h), and malignant metastatic (Ca1a) cells [26,27]. This evidence concerns the gene TGFB1 and breast cancer.